Feature | November 13, 2013

SCAI Highlights Radial Access Best Practices

More interventional cardiologists are performing transradial angioplasty, sparking need for guidance to prevent complications and optimize patient care

cath lab radial access SCAI
November 13, 2013 — The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices for the use of the transradial approach for diagnosing and treating blocked heart arteries. Published online in Catheterization and Cardiovascular Interventions (CCI), the recommendations aim to ensure high-quality patient care as transradial access becomes the preferred technique for catheter-based procedures. Studies show a decreased risk for bleeding and vascular complications, increased patient satisfaction and reduced costs when the transradial approach is used.
  
“While there are a number of benefits to transradial over transfemoral approaches, there are risks associated with any procedure. By emphasizing proper training and highlighting best practices, we aim to ensure that patients receive the advantages of this approach while minimizing any potential complications,” said Sunil Rao, M.D., FSCAI, associate professor of medicine, Duke University and lead author of the consensus statement.
 
In developing this statement, SCAI focused on three core areas to guide physicians:
 
Best practices for avoiding blocked blood flow to the radial (wrist) artery:
Patients should be assessed prior to discharge and at the first post-procedure visit to avoid the potential for radial artery occlusion (RAO), where blood flow to the artery is blocked. Extra care also should be taken to ensure patients receive all relevant strategies for prevention of RAO.
 
Best practices for reducing potential radiation exposure to patient and operators:
To reduce the risk of exposure to radiation during a transradial procedure, the patient’s accessed arm should be placed next to his or her torso. Additional extension tubing should be used and operators should be cognizant of safe radiation protocols.
 
Best practices for physicians transitioning to the transradial approach when treating heart attack:
Studies have shown benefits when patients suffering a heart attack undergo angioplasty via the wrist.  Steps must be taken to ensure physicians have mastered the technique before performing emergency cases routinely from the wrist. This learning process includes understanding when to revert to access through the femoral (groin) artery and how to ensure that using the radial approach does not result in delayed treatment or increased door-to-balloon time.
  
Fore more information: www.scai.org

Related Content

Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab | November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab | November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Overlay Init